Skip to main content
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
26.14
-1.26 (-4.60%)
May 6, 2025, 2:59 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Antibody-cleaving Enzyme Technology Platform
134.09M
Log In
Log In
Log In
Log In
Antibody-cleaving Enzyme Technology Platform Growth
-13.22%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Europe (excluding Sweden)
106.68M
Log In
Log In
Log In
Log In
Europe (excluding Sweden) Growth
24.66%
Log In
Log In
Log In
Log In
North America
27.42M
Log In
Log In
Log In
Log In
North America Growth
-57.34%
Log In
Log In
Log In
Log In
Sweden
-
Log In
Log In
Log In
Log In
Sweden Growth
-
Log In
Log In
Log In
Log In